Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Multicentre, Randomized, Parallel Group Study to Assess the Efficacy and Safety of Oxygen-ozone Therapy Plus Oral Antibiotic Therapy in the Treatment of Infections Secondary to Implant of Orthopaedic Devices

NCT04787575 is registered in ClinicalTrials.gov with Società Scientifica Internazionale di Ossigeno Ozono Terapia as lead sponsor.

NCT NCT04787575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04787575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Multicentre, Randomized, Parallel Group Study to Assess the Efficacy and Safety of Oxygen-ozone Therapy Plus Oral Antibiotic Therapy in the Treatment of Infections Secondary to Implant of Orthopaedic Devices
Lead sponsor
Società Scientifica Internazionale di Ossigeno Ozono Terapia
Phase
Not applicable
Overall status
Unknown status
Start date
January 24, 2024
Completion date
January 31, 2026
Enrollment
186 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

infection